AU5340298A - Stabilized tricyclic compound - Google Patents

Stabilized tricyclic compound

Info

Publication number
AU5340298A
AU5340298A AU53402/98A AU5340298A AU5340298A AU 5340298 A AU5340298 A AU 5340298A AU 53402/98 A AU53402/98 A AU 53402/98A AU 5340298 A AU5340298 A AU 5340298A AU 5340298 A AU5340298 A AU 5340298A
Authority
AU
Australia
Prior art keywords
stabilized
tricyclic compound
tricyclic
compound
stabilized tricyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU53402/98A
Inventor
Soichiro Imoto
Toshio Kashihara
Minoru Yoshioka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU5340298A publication Critical patent/AU5340298A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU53402/98A 1996-12-27 1997-12-25 Stabilized tricyclic compound Withdrawn AU5340298A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP34925696 1996-12-27
JP8-349256 1996-12-27
PCT/JP1997/004819 WO1998029136A1 (en) 1996-12-27 1997-12-25 Stabilized tricyclic compound

Publications (1)

Publication Number Publication Date
AU5340298A true AU5340298A (en) 1998-07-31

Family

ID=18402542

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53402/98A Withdrawn AU5340298A (en) 1996-12-27 1997-12-25 Stabilized tricyclic compound

Country Status (2)

Country Link
AU (1) AU5340298A (en)
WO (1) WO1998029136A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE50011819D1 (en) 1999-03-12 2006-01-12 Aesica Pharmaceuticals Ltd STABLE PHARMACEUTICAL APPLICATION FOR PAROXETIN ANHYDRATE
GB0804755D0 (en) 2008-03-14 2008-04-16 Angeletti P Ist Richerche Bio Therapeutic compounds
TW202216714A (en) * 2020-10-26 2022-05-01 大陸商上海青煜醫藥科技有限公司 Nitrogen-containing fused heterocyclic compound and preparation method and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105791A (en) * 1976-03-22 1978-08-08 The Dow Chemical Company Hypolipidemic cycloalkylaminobenzoic acids
FR2569561B1 (en) * 1984-08-30 1990-05-18 Oreal STABLE ANTHRALIN COMPOSITION IN SATURATED FATTY ACID TRIGLYCERIDES OF PLANT ORIGIN WITH 6 TO 12 CARBON ATOMS
ATE150304T1 (en) * 1990-09-04 1997-04-15 Fujisawa Pharmaceutical Co OINTMENTS CONTAINING TRICYCLIC COMPOUNDS
TW438798B (en) * 1992-10-07 2001-06-07 Pfizer 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions
CN1145030A (en) * 1994-04-07 1997-03-12 史密丝克莱恩比彻姆有限公司 Halofantrine free base for the treatment of malaria and compositions
AU2935895A (en) * 1994-07-15 1996-02-16 Takeda Chemical Industries Ltd. Tricyclic compounds, their production and use

Also Published As

Publication number Publication date
WO1998029136A1 (en) 1998-07-09

Similar Documents

Publication Publication Date Title
AU5703398A (en) Novel compounds
AU3212797A (en) Anti-viral compounds
AUPN842196A0 (en) New compound
AU3057697A (en) Anti-viral compounds
AU4925697A (en) Compounds
AUPN955596A0 (en) New compound
AU3286297A (en) Anti-viral compounds
AU2752597A (en) Anti-viral compounds
AU3620297A (en) Substituted triazoloazinesulphonamides
AU3212897A (en) Anti-viral compounds
AU5423298A (en) Novel compounds
AU3771497A (en) Substituted p-trifluoromethylphenyluracils
AUPO381496A0 (en) New compound
AUPO062696A0 (en) Novel compounds
AU1926397A (en) Substituted 1-methyl-3-benzyluracils
AU1806397A (en) Azo compound
AUPO440596A0 (en) New compound
AU4700497A (en) Organic compounds
AU3711697A (en) Novel compounds
AU5340298A (en) Stabilized tricyclic compound
AU4880997A (en) Lock
AUPO371596A0 (en) New compound
AU2955597A (en) Substituted phenyluracils
AU4641497A (en) Novel compounds
AU1334399A (en) Tricyclic 3-oxo-propanenitrile compounds